Evidence map›Paper›PMID 29241829›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2018

The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.

Constantinos D Paspalas, Becky C Carlyle, Shannon Leslie, Todd M Preuss, Johanna L Crimins, Anita J Huttner, Christopher H van Dyck, Douglas L Rosene, Angus C Nairn, Amy F T Arnsten

Open access · hybridAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Constantinos D PaspalasDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA. Electronic address: constantinos.paspalas@yale.edu.
Becky C CarlyleDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Shannon LeslieDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Todd M PreussDivision of Neuropharmacology and Neurologic Diseases, Yerkes National Primate Center, Emory University, Atlanta, GA, USA.
Johanna L CriminsDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA.
Anita J HuttnerDepartment of Pathology, Yale School of Medicine, New Haven, CT, USA.
Christopher H van DyckDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA; Department of Neurology, Yale School of Medicine, New Haven, CT, USA.
Douglas L RoseneDepartment of Anatomy and Neurobiology, Boston University School of Medicine, Boston, MA, USA.
Angus C NairnDepartment of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
Amy F T ArnstenDepartment of Neuroscience, Yale School of Medicine, New Haven, CT, USA; Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA. Electronic address: amy.arnsten@yale.edu.
Yale University · USBoston University · USEmory University · US

Funding

Yerkes National Primate Research Center Role of type-I IFN in regulating COVID-19 induced inflammation and pathogenesisP51OD011132 · OD · EMORY UNIVERSITY · PI Joon Sup Lee · 2012 to 2026
$167.0M
Yale Alzheimer Disease Research CenterP50AG047270 · NIA · YALE UNIVERSITY · PI NAIRN, ANGUS C. · 2015 to 2019
$8.3M
Highly evolved brain circuits in primates: molecular vulnerabilities for diseaseDP1AG047744 · NIA · YALE UNIVERSITY · PI ARNSTEN, AMY F.T. · 2013 to 2017
$4.1M
Histopathology, Neuroimaging and Mechanism of Myelin Damage in Aging Monkey BrainR01AG043640 · NIA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ROSENE, DOUGLAS L · 2013 to 2017
$3.0M
NIA NIH HHS DP1 AG047744NIA NIH HHS P50 AG047270NIA NIH HHS R01 AG043640NIH HHS P51 OD011132
6 · The paper itself

Abstract

introductionAn animal model of late-onset Alzheimer's disease is needed to research what causes degeneration in the absence of dominant genetic insults and why the association cortex is particularly vulnerable to degeneration.

methodsWe studied the progression of tau and amyloid cortical pathology in the aging rhesus macaque using immunoelectron microscopy and biochemical assays.

resultsAging macaques exhibited the same qualitative pattern and sequence of tau and amyloid cortical pathology as humans, reaching Braak stage III/IV. Pathology began in the young-adult entorhinal cortex with protein kinase A-phosphorylation of tau, progressing to fibrillation with paired helical filaments and mature tangles in oldest animals. Tau pathology in the dorsolateral prefrontal cortex paralleled but lagged behind the entorhinal cortex, not afflicting the primary visual cortex. DISCUSSION: The aging rhesus macaque provides the long-sought animal model for exploring the etiology of late-onset Alzheimer's disease and for testing preventive strategies.

Indexed as

Disease Models, AnimalDisease ProgressionMacaca mulattaAgingAlzheimer DiseaseAmyloidAnimalsBrainEntorhinal CortexMicroscopy, ImmunoelectronNeurofibrillary TanglesPhosphorylationPlaque, AmyloidPrefrontal Cortextau ProteinsAmyloidtau ProteinsAmyloidAnimal model of diseaseEntorhinal cortexPrefrontal cortexRyanodine receptor calcium leakTau phosphorylation

Identifiers

PMID29241829
PMCPMC6178089
OpenAlexW2772269246

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.